largest Fontan clinical trial Shaping the future of the Fontan community We strive to discover, develop and deliver new hope for people living with Fontan circulation. Faces of Fontan Highlighting the real-life experiences of people living with Fontan circulation....
Dr. James Yeager, Chief Operating Officer of Mezzion Pharmaceuticals Inc., commented, “This NDA-resubmission was a large-scale comprehensive global effort coordinated with all FUEL study sites, study site pers...